WAGG, A.; FRANKS, B.; RAMOS, B.; BERNER, T. Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada. Canadian Urological Association Journal, [S. l.], v. 9, n. 9-10, p. 343–50, 2015. DOI: 10.5489/cuaj.3098. Disponível em: https://cuaj.ca/index.php/journal/article/view/3098. Acesso em: 20 apr. 2024.